Home > Healthcare > Medical Devices > Therapeutic Devices > Platelet Rich Plasma (PRP) Market

Platelet Rich Plasma (PRP) Market Share

Report ID: GMI10133
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Platelet Rich Plasma Market Share

The platelet-rich plasma industry is characterized by a competitive landscape shaped by a mix of established players and emerging entrants striving to capitalize on the growing demand for regenerative medicine solutions. Key players such as Harvest Technologies (Terumo BCT), Arthrex Inc., and DePuy Synthes (Johnson & Johnson) dominate the market with their extensive product portfolios and strong distribution networks. The competitive dynamics are further fuelled by strategic partnerships, mergers, and acquisitions aimed at expanding market presence and accelerating product development cycles in this rapidly evolving sector.

Platelet Rich Plasma Market Companies

Prominent players operating in the platelet rich plasma industry include:

Arthrex Inc.
APEX Biologix
Celling Biosciences, Inc.
DePuy Synthes (Johnson & Johnson)
Dr. PRP USA LLC
EmCyte Corporation
Exactech, Inc.
Glofinn Oy
Isto Biologics
Juventix Regenerative Medical, LLC.
Regen Lab SA
Terumo BCT, Inc.
ThermoGenesis Holdings Inc.
Vivostat A/S

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global platelet rich plasma industry was valued at USD 479.6 million in 2023 and is anticipated to register 10.6% CAGR between 2024 and 2032 due to the increasing prevalence of sports injuries and orthopedic conditions.

The pure segment in the PRP market accounted for USD 211.1 million, attributed to its extensive application in various medical and aesthetic procedures.

North America platelet rich plasma industry is anticipated to reach USD 395.4 million by 2032, driven by robust healthcare infrastructure, and high adoption rates of regenerative medicine technologies.

Arthrex Inc., APEX Biologix, Celling Biosciences, Inc., DePuy Synthes (Johnson & Johnson), Dr. PRP USA LLC, EmCyte Corporation, Exactech, Inc., Glofinn Oy, Isto Biologics, Juventix Regenerative Medical, LLC., and Regen Lab SA., among others.